Advisor Kudos to Howard Wolinsky!

Advisor Kudos to Howard Wolinsky!

Congrats to AnCan Advisor and  Active Surveillance Prostate Cancer Virtual Support Group Moderator, Howard Wolinsky, for receiving the Best In-depth Report or Series Lisagor Award from the Chicago Headline Club  for his article in Chicago Medicine on “The debate over gadolinium-based contrast agents

For those who attend this group, they are well aware that gadolinium contrast is a frequent topic of conversation. This may have even spurred Howard into his excellent in-depth report on the dangers associated with the use of this scanning contrast.

Onward & upwards, Howard ….. keep generating that social profit!

Join SUPER HealtheVoices Live this Saturday, April 25 – all invited!!!

Some of you may already be aware of Janssen/J&J’s annual patient advocate conference, HealtheVoices, that is usually by invitation only based on a competitive application process. This year’s pandemic has sent the Conference virtual, and it is open to ALL! The conference covers the spectrum of conditions from mental to physical, and from cancer to rare diseases.
#HealtheVoicesLIVE 2020 is this Saturday, April 25 starting from 11 am – 8.30 pm Eastern. You can find the full agenda and link to join HERE. Feel free to pop in and out during the day and tune in to presentations and events of interest to each of you.There are presentations, interviews and even small group breakouts allowing you to interact with leading national advocates for differing conditions.
Please note the links to join change for the morning and afternoon sessions:

To join the broadcast between 11 a.m. and 3:30 p.m. ET, click this link.

To join the broadcast between 3:30 p.m. and 8:30 p.m. ET, click this link.

For the best experience, join the meeting via Google Chrome

I will be presenting in the 3rd Hour; the session starts at 1.30 pm Eastern and I am due up first as part of 4 flash sessions followed by a Q&A. I will be offering tips on virtual moderation – a skill many patient advocates have had to quickly familiarize themselves with in the past few weeks. But as you all know, we’ve been at this game for many years!!
Please join me and HeV, enjoy the conference, learn a little, and above all – stay safe, well and have fun!
Onward & upwards, rd
Focal treatment for Urologic Cancer .. and perhaps other cancers???

Focal treatment for Urologic Cancer .. and perhaps other cancers???

https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/120402-12th-international-symposium-on-focal-therapy-and-imaging-in-prostate-and-kidney-cancer.html

In the context of prostate cancer, newly diagnosed men with low and intermediate disease often consider focal therapy modes such as cryotherapy, HIFU or targeted radiation for intial treatment. And more frequently, we are seeing some of these modes employed for adjuvant and salvage therapy.

AnCan’s good friend, John Fortin, just published a short report on UroToday summarizing the findings from a Febraury 2020 Conference that considered focal therapy. This may well be of interest to other cancers, like ovarian and breast, where focal modes are also employed. John’s report linked above does not address follow-up treatment in the case of recurrent disease after intial treatment.

 

PCRI goes VIRTUAL for its Mid-Year Update Conference

PCRI goes VIRTUAL for its Mid-Year Update Conference

For our prostate cancer followers, patients & caregivers, PCRI announced yesterday that its mid-year one-day conference on Saturday, March 28 will now be held as a virtual gathering with a live FREE stream …. all you need do is register here.

The conference features as always the dynamic variety duo, Drs. Mark Moyad and Mark Scholz. They will be joined by 3 excellent speakers:

  • GU Medical Oncologists, Dr. Evan  YU from Seatle Cancer Alliance/ University of Washington Med School
  • Radiation Oncologist, Dr. Jeffrey Demanes from UCLA
  • Genomic specialist, Dr. Joannne Wiedhaas, UCLA

Each speaker will be followed by Q&A fielding your written questions that can be submitted ahead of time. And it will conclude with 90′ of Q&A with Moyad & Scholtz.

This is a terrific opportunity for you to ask the experts all those questions your own medical team has not answered completely and/or we are not fielding in one of our NINE, yes 9!, monthly VIRTUAL PC support groups. AND this crew will respond to personal situations and provide somewhat filtered medical advice that we cannot do.

That should cover it all, but just in case not, here again is the PCRI Conference website:

https://pcri.org/2020-midyear-update#myu-speakers-topics

See you there … O&U, rd

Active Surveillance Prostate Cancer

Active Surveillance Prostate Cancer

Active Surveillance Prostate Cancer Virtual Support Group

Active Surveillance (AS) for low-risk prostate cancer presents its own challenges that are very different from other treatment protocols. This virtual group is for men and caregivers on or considering AS to treat their condition. New participants are given priority to discuss their situation.  Click here for detailed information.

1st, 2nd & 3rd Wednesdays & 4th Thursdays of each month at 8 pm EST/EDT (US)

Moderators: Joe GalloKen Mason, Howard Wolinsky, Alexa Jett, Hugh Idstein.

Co-sponsors: UsTOO